This brand name is authorized in Nigeria.
The drug GECIP-TN contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
|
|
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
|
2
|
UNII
033KF7V46H - TINIDAZOLE
|
|
Tinidazole is active against both protozoa and obligate anaerobic bacteria. The activity against protozoa involves Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. The mode of action of tinidazole against anaerobic bacteria and protozoa involves penetration of the drug into the cell of the micro-organism and subsequent damage of DNA strands or inhibition of their synthesis. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| C4-0166 | Tablet | GECIP-TN 500/600 MG TABLETS TAB 500 mg; 600 mg 1 X 10 | 189 CMS-PP-333654 GECIP-TN 500/600 MG TABLETS CIPROFLOXACIN, TINIDAZOLE 500/600 MG - CIPROFLOXACIN HYDROCHLORIDE USP EQ. TO CIPROFLOXACIN 500 MG TINIDAZOLE BP 600 MG EXCIPIENTS: Sodium Lauryl Sulphate, Crospovidone Type A, Povidone K-30, Colloidal Anhydrous Silica, Magnesium Stearate, Coating Premix Orange, Isopropyl alcohol, Dichloromethane. C4-0166 Drugs Imported Products 110 POM 1 5/23/2023 GENEITH PHARMACEUTICALS LIMITED, ADEWALE CRESCENT, OFF EWENLA STREET, OSHODI ISOLO LAGOS 8122912281 ngouzoamaka@yahoo.com NOVAGEN HEALTHCARE PVT. LTD, PLOT NO. 102-111, HORIZON IND. PARK, N.H. NO.48 AT: BAMANGAM, DIST-VADODARA-391 243 GUJARAT STATE, INDIA., India | 06/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01RA11 | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01R Combinations of antibacterials → J01RA Combinations of antibacterials | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | C4-0166 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.